Avalo Therapeutics (AVTX)
(Delayed Data from NSDQ)
$12.59 USD
+0.95 (8.16%)
Updated Jul 5, 2024 03:39 PM ET
After-Market: $12.34 -0.25 (-1.99%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth C Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/01/2024
Time: -- |
6/2024 | $-0.19 | 0.00% |
Earnings Summary
For their last quarter, Avalo Therapeutics (AVTX) reported earnings of -$5.98 per share, missing the Zacks Consensus Estimate of -$1.18 per share. This reflects a negative earnings surprise of 406.78%. Look out for AVTX's next earnings release expected on August 01, 2024. For the next earning release, we expect the company to report earnings of -$0.19 per share, reflecting a year-over-year increase of 99.86%.
Earnings History
Price & Consensus
Zacks News for AVTX
Is Avalo Therapeutics (AVTX) Stock Outpacing Its Medical Peers This Year?
AVTX: What are Zacks experts saying now?
Zacks Private Portfolio Services